Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor

Blood

Volumn 92, Issue 11, 1998, Pages 4238-4247

  Brossart, Peter ^a   Grünebach, Frank ^a   Stuhler, Gernot ^a   Reichardt, Volker L ^a   Möhle, Robert ^a   Kanz, Lothar ^a   Brugger, Wolfram ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ARTICLE; CELL ADHESION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE REACTION; MONOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0032403453     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.11.4238     Document Type: Article

References (49)

1. Steinman AM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271, 1991
2. Steinman RM, Witmer-Pack M, Inaba K: Dendritic cells: Antigen presentation, accessory function and clinical relevance. Adv Exp Med Biol 329:1, 1993
3. Austyn JM: New insight into the mobilisation and phagocytic activity of dendritic cells. J Exp Med 183:1287, 1996
4. Cella M, Sallusto F, Lanzavecchia A: Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10, 1997
5. Inaba K, Metlay JP, Crowley MT, Steinman RM: Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med 172:631, 1990
6. Nair S, Zhou F, Reddy R, Huang L, Rouse BT: Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. J Exp Med 175:609, 1992
7. Porgador A, Gilboa E: Bone-marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 182:255, 1995
8. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD: Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J Exp Med 183:283, 1996
9. Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ: Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183:87, 1996
10. Porgador A, Snyder D, Gilboa E: Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol 156:2918, 1996
11. Paglia P, Chiodoni C, Rodolfo M, Colombo MP: Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 183:317, 1996
12. Brossart P, Goldrath AW, Butz EA, Martin S, Bevan MJ: Adenovirus mediated delivery of antigenic epitopes into DC by a means of CTL induction. J Immunol 158:3270, 1997
13. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J: GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258, 1992
14. Bernhard H, Disis ML, Heimfeld S, Hand S, Gralow JR, Cheever MA: Generetion of immunostimulatorry dendritic cells from human CD34+ hematopoetic progenitor cells of th bone marrow and periphereal blood. Cancer Res 55:1099, 1995
15. Young JW, Szabolcs P, Moore MA: Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha. J Exp Med 183:1283, 1996
16. Fisch P, Köhler G, Garbe A, Herbst B, Wider D, Kohler H, Schaefer HE, Mertelsmann R, Brugger W, Kanz L: Generation of antigen-presenting cells for soluble protein antigens ex vivo from peripheral blood CD34+hematopoetic progenitor cells in cancer patients. Eur J Immunol 26:595, 1996
17. Scheding S, Wirths S, Bühring HJ, Ziegler B, Bock T, Kanz L, Brugger W: FLT-3 ligand, TGF-β, and GM-CSF/II-4 are critical growth factors for the induction of CD1a+/CD14-/CD80+ dendritic cells (DC) from CD34+ peripheral blood progenitor cells in serum-free medium. Blood 90:478a, 1997
18. Flores-Romo L, Björck P, Duvert V, van Kooten C, Sealand S, Banchereau J: CD40 ligation on human cord blood CD34+ hematopoetic progenitors induces their proliferation and differentiation into functional dendritic cells. J Exp Med 185:341, 1997
19. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony stimulating factor plus Interieukin 4 and down regulated by tumour necrosis factor alpha. J Exp Med 179:1109, 1994
20. Sallusto F, Cella M, Danieli C, Lanzavecchia A: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macro-molecules in the Major Histocomptibility Complex class II compartment: Down regulation by cytokines and bacterial products. J Exp Med 182:389, 1995
21. Zhou L, Tedder TF: CD14 blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 93:2588, 1996
22. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P,Gluckman JC: Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 27:431, 1997
23. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B, Niederwieser D, Schuler G: Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196:137, 1996
24. Metcalf D, Shortman K, Vremec D, Migsud S, Di-Rago L: Effects of excess GM-CSF levels on hematopoesis and leukemia development in GM-CSF/macs 41 double transgenic mice. Leukemia 10:713, 1996
25. Dranoff G, Crawford AD, Sadelain M, Ream B, Bronson RT, Dickersin GR, Bachurski CJ, Mark EL, Whitsett JA, Mulligan RC: Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264:713, 1994
26. Maraskowsky E, Brasel K, Teepe M, Roux ER, Lyman SD, Shortman K, McKenna HJ: Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified. J Exp Med 184:1953, 1996
27. Maraskowsky E, Roux E, Teepe M, McKenna HJ, Brasel K, Lyman SD, Williams DE: The effect of Flt3 ligand and/or c-kit ligand on the generation of dendritic cells from human CD34+ bone marrow. Blood 86:420, 1995
28. Strobl H, Bello-Fernandez C, Riedl E, Pickl WF, Majdic O, Lyman SD, Knapp W: Flt3 ligand in cooperation with transforming growth factor-1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood 90:1425, 1997
29. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle J: Immune regulation by CD40 and its ligand gp39. Annu Rev Immunol 14:591, 1996
30. Grewal IS, Flavell RA: The role of CD40 ligand in costimulation and T-cell activation. Immunol Rev 153:85, 1996
31. Van Kooten C, Banchereau J: Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol 9:330, 1997
32. Caux C, Massacrier C, Vianbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J: Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263, 1994
33. Brossart P, Bevan MJ: Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self-peptide. J Exp Med 183:2449, 1996
34. Brossart P, Schmier JW, Krüger S, Willhauck M, Scheibenbogen C, Mönler T, Keilholz U: A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 55:4065, 1995
35. Adema GJ, Hartges F, Verstraten R, de Vries E, Marland G, Menon S, Foster J, Xu Y, Nooyen P, McClanahan T, Bacon KB, Figdor CG: A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387:713, 1997
36. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita K, Namba M, Tanabe F, Konishi K, Fukuda F, Kurimoto M: Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378:88, 1995
37. Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, Tanabe F, Konishi K, Micallef M, Fujii M, Torigoe K, Tanimoto T, Fukuda S, Ikeda M, Okamura H, Kurimoto M: Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 156:4274, 1996
38. Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, Ikeda M, Kurimoto M: IFN-gamma-inducing factor (IGIF) is a costimulutory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 158:1541, 1997
39. Yoshimoto T, Okamura H, Tagawa YI, Iwakura Y, Nakahashi K: Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-production from activated B cells. Proc Natl Acad Sci USA 94:3948, 1997
40. Stoll S, Müller G, Kurimoto M, Saloga J, Tanimoto T, Yamauchi H, Okamura H, Knop J, Enk AH: Production of IL-18 (IFN-γ-inducing factor) messenger RNA and functional protein by murine keratinocytes. J Immunol 159:298, 1997
41. Lyman SD, James L, Bos TV, de Vries P, Brasel K, Gliniak B, Hollingworth LT, Picha KS, McKenna HJ, Splett RR, Fletcher FA, Maraskovsky E, Farrah T, Foxworthe D, Williams DE, Beckmann MP: Molecular cloning of a ligand for the flt3/flk-2 tyrosinase kinase receptor: A proliferative factor for primitive hematopoetic cells. Cell 75:1157, 1993
42. Bevan MJ: Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 143:1283, 1976
43. York IA, Rock KL: Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol 14:369, 1996
44. Huang, AYC, Golumbeck P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H: Role of bone marrow derived cells in presenting MHC class I-restricted tumour antigens. Science 264:961, 1994
45. Norbury CC, Hewlett LJ, Prescott AR, Shastri N, Watts C: Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 3:783, 1995
46. Norbury CC, Chambers BJ, Prescott AR, Ljunggren HG, Watts C: Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur J Immunol 27:280, 1997
47. Shen Z, Reznikoff G, Dranoff G, Rock KL: Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 158:2723, 1997
48. Brossart P, Bevan MJ: Presentation of exogenous antigens on MHC class I molecules by dendritic cells: Pathway of presentation and regulation by cytokines. Blood 90:1594, 1997
49. Bennett SRM, Carbone FR, Karamalis F, Miller JFAP, Heath W: Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med 186:65, 1997